Gynecologic cancer
Conditions
Interventions
None listed
Sponsors
The University of Tokyo
Aichi Cancer Center Jichi Medical University Hospital Saitama Medical University Internal Medical Center Gunma university hospital Hyogo Cancer Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) ovarian cancer (high risk I, high risk stage II, stage III, stage IV, recurrence), cervix cancer (stage IV, recurrence), endometorial cancer (high risk I, high risk stage II, stage III, stage IV, recurrence) in accordance with FIGO classification 2) receiving chemotherapy more than 2 month as of IC 3) scheduling to receive chemotherapy more than 1 month from IC 4) more than 20 years old 5) judged as not eligible by physician
Exclusion criteria
Exclusion criteria: 1) complication affects QoL significantly 2) difficult to answer questionnaire 3) Lack of consent ability such as dementia 4) no payment or extremely less payment for medical expense 5) judged as not appropriate by physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between COST score and QoL score (EQ-5D-5L, EORTC-QLQ) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) validation of COST questionnaire among patient with gynecologic cancer 2) relation between COST score and each factors 3) change over time of COST score 4) validation of EORTC-QLQ among patient with gynecologic cancer 5) health economics | — |
Countries
Japan
Contacts
Public ContactYusuke Kajimoto
The University of Tokyo Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences
Outcome results
None listed